Experimental muscle cell injection trial opens for duchenne patients
NCT ID NCT06692426
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-phase trial tests whether injecting lab-grown muscle cells (MyoPAXon) into the foot is safe for adults with Duchenne muscular dystrophy who can no longer walk. Eight participants will receive the cells along with an immunosuppressant drug to prevent rejection. The main goal is to find a safe dose, not to measure improvement.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
MyoPAXon (iPSC-derived muscle progenitor cells) plus tacrolimus (immunosuppressant)
What this could lead to
If safe, this could pave the way for a treatment that helps repair muscle in people with Duchenne muscular dystrophy.
What could go wrong
This is a very early, small safety trial with only 8 participants. It is not designed to prove the treatment works, and participants must take lifelong immunosuppressants, which carry serious risks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DUCHENNE MUSCULAR DYSTROPHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Masonic Cancer Center
RECRUITINGMinneapolis, Minnesota, 55455, United States
Contact